A Microdose Study to Describe the Intravenous Pharmacokinetics of GSK3191607 in Healthy Male Subjects Following Administration of [14C]-GSK3191607
Phase of Trial: Phase I
Latest Information Update: 22 Nov 2017
At a glance
- Drugs GSK 3191607 (Primary)
- Indications Falciparum malaria
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline
- 22 Nov 2017 Results published in the British Journal of Clinical Pharmacology
- 06 Jun 2016 Status changed from active, no longer recruiting to completed.
- 28 Apr 2016 Status changed from not yet recruiting to active, no longer recruiting.